Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ELTXElicio Therapeutics, Inc.

Nasdaq · CIK 0001601485
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts306

Identity from submissions API

NameElicio Therapeutics, Inc.
CIK0001601485
TickersELTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN113430072
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(857) 209-0050
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Angion Biomedica Corp. (2014-03-04T00:00:00.000Z → 2023-05-30T00:00:00.000Z)
Business address
451 D STREET, 5TH FLOOR
BOSTON
MA
02210
MA
Mailing address
451 D STREET, 5TH FLOOR
BOSTON
MA
02210
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

385 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 8-K 8-K 5.07 0001601485-26-000070 001-39990 261552254 34 149098 1 1
2026-11-05 10-Q 10-Q 0001601485-26-000066 001-39990 261527525 34 8883221 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001601485-26-000065 001-39990 261527468 34 2199478 1 1
2026-10-09 DEF 14A DEF 14A 0001601485-26-000061 001-39990 261452954 34 5666760 1 1
2026-09-14 8-K 8-K 5.08,8.01 0001601485-26-000058 001-39990 261377328 34 143142 1 1
2026-09-02 4 FORM 4 0001230486-26-000002 5872
2026-09-02 4 FORM 4 0001761748-26-000002 5891
2026-09-02 4 FORM 4 0001979324-26-000002 5917
2026-09-02 4 FORM 4 0001441889-26-000002 5918
2026-09-02 4 FORM 4 0001187308-26-000004 5861
2026-09-02 4 FORM 4 0001267490-26-000010 5976
2026-09-02 4 FORM 4 0001413350-26-000009 346780
2026-08-13 10-Q 10-Q 0001601485-26-000056 001-39990 261273315 34 7760401 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001601485-26-000055 001-39990 261273260 34 2138449 1 1
2026-07-17 4 FORM 4 0001612095-26-000002 5825
2026-07-17 4 FORM 4 0001979163-26-000002 5766
2026-07-17 4 FORM 4 0001787403-26-000002 5800
2026-07-17 4 FORM 4 0001796436-26-000002 5769
2026-07-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002145902-26-000001 005-93548 261179241 34 6729
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-081751 005-93548 261162005 34 9604
2026-07-02 424B5 424B5 0001104659-26-080106 333-293861 261147815 33 562425
2026-07-02 8-K FORM 8-K 1.01,8.01,9.01 0001104659-26-080058 001-39990 261147658 34 650638 1 1
2026-06-24 8-K 8-K 7.01 0001601485-26-000050 001-39990 261115910 34 3961748 1 1
2026-06-17 8-K 8-K 8.01 0001601485-26-000048 001-39990 261096636 34 1972927 1 1
2026-06-15 8-K 8-K 8.01 0001601485-26-000046 001-39990 261089211 34 4860578 1 1
2026-05-11 10-Q 10-Q 0001601485-26-000042 001-39990 26963337 34 7186024 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001601485-26-000041 001-39990 26963248 34 2009264 1 1
2026-04-29 10-K/A 10-K/A 0001601485-26-000035 001-39990 26915891 34 984305 1 1
2026-03-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000830 333-293861 26758878 33 1816
2026-03-16 8-K 8-K 1.01,1.02 0001601485-26-000032 001-39990 26754755 34 17339499 1 1
2026-03-16 424B5 424B5 0001628280-26-017941 333-293861 26754751 33 475812
2026-03-12 S-8 S-8 0001601485-26-000030 333-294253 26748471 33 833239 1 1
2026-03-12 CORRESP filename1.htm 0001601485-26-000029 8336
2026-03-12 S-3/A S-3/A 0001628280-26-017302 333-293861 26748369 33 394808
2026-03-12 10-K 10-K 0001601485-26-000027 001-39990 26748140 34 20496020 1 1
2026-03-12 8-K 8-K 2.02 0001601485-26-000026 001-39990 26747732 34 2176101 1 1
2026-03-06 UPLOAD filename1.pdf 0000000000-26-002334 333-293861 40156
2026-03-02 S-3/A S-3/A 0001628280-26-013187 333-293861 26707527 33 97011
2026-02-27 S-3 S-3 0001628280-26-012826 333-293861 26700064 33 1295907 1 1
2026-02-03 4 FORM 4 0001601485-26-000010 7572
2026-02-03 4 FORM 4 0001601485-26-000008 7602
2026-02-03 4 FORM 4 0001601485-26-000006 7568
2026-02-03 4 FORM 4 0001601485-26-000002 7627
2025-12-10 4 FORM 4 0001601485-25-000130 6889
2025-12-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003510 333-291515 251548156 33 1817
2025-12-01 CORRESP filename1.htm 0001601485-25-000128 8398
2025-11-13 S-3 S-3 0001628280-25-052119 333-291515 251479585 33 412276 1 1
2025-11-13 10-Q 10-Q 0001601485-25-000124 001-39990 251478485 34 7710846 1 1
2025-11-13 8-K 8-K 2.02 0001601485-25-000123 001-39990 251478292 34 2105260 1 1
2025-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002050492-25-000003 005-93548 251378797 34 7261
2025-09-17 8-K 8-K 7.01,8.01,9.01 0001193125-25-205522 001-39990 251318819 34 1925492 1 1
2025-08-12 8-K 8-K 8.01 0001601485-25-000114 001-39990 251204110 34 1974631 1 1
2025-08-07 10-Q 10-Q 0001601485-25-000111 001-39990 251194991 34 7537704 1 1
2025-08-07 8-K 8-K 2.02 0001601485-25-000108 001-39990 251194739 34 1944405 1 1
2025-08-05 8-K 8-K 8.01 0001601485-25-000099 001-39990 251182766 34 1652651 1 1
2025-06-04 4 4 0000950170-25-081741 7052
2025-06-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-081739 005-93548 251024010 34 12125
2025-06-04 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001601485-25-000096 001-39990 251021948 34 24751354 1 1
2025-05-20 4 FORM 4 0001601485-25-000090 5593
2025-05-20 4 FORM 4 0001601485-25-000089 5620
2025-05-20 4 FORM 4 0001601485-25-000088 5637
2025-05-20 4 FORM 4 0001601485-25-000087 5574
2025-05-20 4 FORM 4 0001601485-25-000086 5678
2025-05-20 4 FORM 4 0001601485-25-000085 5448
2025-05-20 4 FORM 4 0001601485-25-000084 5619
2025-05-20 8-K 8-K 5.07 0001601485-25-000076 001-39990 25966208 34 151412 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002050492-25-000001 005-93548 25943058 34 7451
2025-05-13 10-Q 10-Q 0001601485-25-000074 001-39990 25940675 34 7714669 1 1
2025-05-13 8-K 8-K 2.02 0001601485-25-000072 001-39990 25940581 34 1964722 1 1
2025-04-16 4 FORM 4 0001601485-25-000065 5684
2025-04-09 ARS ARS 0001601485-25-000063 001-39990 25825451 34 10592419
2025-04-09 DEF 14A DEF 14A 0001601485-25-000062 001-39990 25825435 34 2610167 1 1
2025-04-02 3 FORM 3 0001601485-25-000053 3229
2025-03-31 S-8 S-8 0001601485-25-000051 333-286242 25788827 33 787267
2025-03-31 10-K 10-K 0001601485-25-000049 001-39990 25788822 34 14759630 1 1
2025-03-31 8-K 8-K 2.02 0001601485-25-000046 001-39990 25788804 34 1417957 1 1
2025-03-24 8-K 8-K 5.02 0001601485-25-000022 001-39990 25762198 34 2962085 1 1
2025-03-07 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-035497 005-93548 25720073 34 14131
2025-03-07 4 4 0000950170-25-035494 8939
2025-03-05 8-K 8-K 3.02 0001601485-25-000018 001-39990 25710919 34 150522 1 1
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-009441 005-93548 25591626 34 9383
2025-02-04 4 FORM 4 0001601485-25-000016 5638
2025-02-04 4 FORM 4 0001601485-25-000014 5697
2025-02-04 4 FORM 4 0001601485-25-000012 5641
2025-01-30 8-K 8-K 1.01,8.01,9.01 0001193125-25-016455 001-39990 25571318 34 524693 1 1
2025-01-30 424B5 424B5 0001193125-25-016368 333-279925 25571269 33 477928
2025-01-23 8-K 8-K 7.01 0001601485-25-000009 001-39990 25550617 34 4641589 1 1
2025-01-22 8-K 8-K 8.01 0001601485-25-000006 001-39990 25543893 34 1106900 1 1
2025-01-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-002866 005-93548 25515202 34 7126
2025-01-02 4/A FORM 4/A 0001601485-25-000002 8615
2024-12-18 4 FORM 4 0001601485-24-000109 6896
2024-12-12 8-K 8-K 7.01,8.01 0001601485-24-000107 001-39990 241543251 34 5783419 1 1
2024-12-03 8-K 8-K 8.01,9.01 0001193125-24-269400 001-39990 241521056 34 179564 1 1
2024-11-29 4 FORM 4 0001601485-24-000105 8056
2024-11-25 4 FORM 4 0001601485-24-000101 5691
2024-11-25 4 FORM 4 0001601485-24-000099 5587
2024-11-25 4 FORM 4 0001601485-24-000097 5606
2024-11-25 4 FORM 4 0001601485-24-000095 5650
2024-11-25 4 FORM 4 0001601485-24-000093 5461
2024-11-25 4 FORM 4 0001601485-24-000091 5632
2024-11-25 4 FORM 4 0001601485-24-000089 5633
2024-11-22 424B3 424B3 0001601485-24-000087 333-283199 241486501 33 158632
2024-11-21 8-K 8-K 5.07 0001601485-24-000083 001-39990 241484276 34 162996 1 1
2024-11-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-11-20 16:00:00 9999999995-24-003532 333-283199 241482009 33 1824
2024-11-18 CORRESP filename1.htm 0001601485-24-000081 163390
2024-11-15 UPLOAD filename1.pdf 0000000000-24-012681 333-283199 40156
2024-11-13 S-3 S-3 0001601485-24-000078 333-283199 241454622 33 929267
2024-11-13 10-Q 10-Q 0001601485-24-000075 001-39990 241454312 34 34952077 1 1
2024-11-13 8-K 8-K 2.02 0001601485-24-000074 001-39990 241454243 34 1694844 1 1
2024-11-07 8-K 8-K 8.01 0001601485-24-000067 001-39990 241436269 34 1238370 1 1
2024-11-07 8-K 8-K 8.01 0001601485-24-000063 001-39990 241433540 34 151704 1 1
2024-10-17 8-K 8-K 5.02 0001601485-24-000057 001-39990 241375960 34 152601 1 1
2024-10-02 4 FORM 4 0001601485-24-000053 5650
2024-10-02 4 FORM 4 0001601485-24-000051 5650
2024-10-02 4 FORM 4 0001601485-24-000049 5715
2024-09-27 ARS ARS 0001140361-24-042211 001-39990 241335547 34 1676868
2024-09-27 DEF 14A DEF 14A 0001140361-24-042209 001-39990 241335523 34 3369807
2024-09-17 PRE 14A PRE 14A 0001140361-24-041303 001-39990 241304262 34 3370094
2024-08-30 8-K 8-K 5.02 0001140361-24-039592 001-39990 241266056 34 162508 1 1
2024-08-14 SC 13D/A GKCC, LLC ELICIO THERAPEUTICS, INC. SCHEDULE 13D/A 0001068238-24-000167 005-93548 241209305 34 87051
2024-08-14 4 FORM 4 0001140361-24-037346 7747
2024-08-13 10-Q 10-Q 0001601485-24-000045 001-39990 241202634 34 6781516 1 1
2024-08-13 8-K 8-K 2.02 0001601485-24-000042 001-39990 241202234 34 1943282 1 1
2024-08-12 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001140361-24-036848 001-39990 241197120 34 856965 1 1
2024-07-02 4 FORM 4 0001140361-24-032293 21143
2024-07-02 SC 13D/A GKCC, LLC ELICIO THERAPEUTICS, INC SCHEDULE 13D/A 0001068238-24-000141 005-93548 241096250 34 79032
2024-07-02 4 FORM 4 0001140361-24-032163 9318
2024-07-01 424B5 424B5 0001140361-24-031819 333-279925 241087580 33 818762
2024-07-01 8-K FORM 8-K 1.01,8.01,9.01 0001140361-24-031811 001-39990 241087392 34 995689 1 1
2024-06-27 424B5 424B5 0001140361-24-031588 333-279925 241079852 33 818865
2024-06-27 8-K 8-K 7.01,8.01,9.01 0001140361-24-031563 001-39990 241079243 34 10395740 1 1
2024-06-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-11 16:00:00 9999999995-24-001817 333-279925 241037426 33 1824
2024-06-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-06-11 16:00:00 9999999995-24-001809 333-278373 241037418 33 1824
2024-06-10 CORRESP filename1.htm 0001140361-24-029562 6920
2024-06-07 CORRESP filename1.htm 0001140361-24-029282 8204
2024-06-06 UPLOAD filename1.pdf 0000000000-24-006540 333-279925 40406
2024-06-03 S-3 S-3 0001140361-24-028642 333-279925 241015035 33 2011561
2024-06-03 CORRESP filename1.htm 0001140361-24-028584 37146
2024-06-03 S-3/A ny20025434x3_s3a.htm 0001140361-24-028580 333-278373 241014335 33 344415
2024-05-24 8-K 8-K 8.01 0001601485-24-000037 001-39990 24979950 34 1569816 1 1
2024-05-15 10-Q 10-Q 0001601485-24-000033 001-39990 24951900 34 22870720 1 1
2024-05-15 8-K 8-K 2.02 0001601485-24-000032 001-39990 24951831 34 1750260 1 1
2024-04-29 10-K/A 10-K/A 0001140361-24-022682 001-39990 24886540 34 897209 1 1
2024-04-10 SC 13D/A SC 13D/A 0001193125-24-091853 005-93548 24835732 34 130534
2024-04-10 UPLOAD filename1.pdf 0000000000-24-003869 333-278373 45489
2024-04-05 8-K 8-K 8.01 0001601485-24-000025 001-39990 24826991 34 2042264 1 1
2024-03-29 S-8 FORM S-8 0001140361-24-016577 333-278374 24803928 33 128215
2024-03-29 S-3 S-3 0001140361-24-016574 333-278373 24803923 33 323589
2024-03-29 10-K 10-K 0001601485-24-000023 001-39990 24803540 34 32427455 1 1
2024-03-29 8-K 8-K 2.02 0001601485-24-000021 001-39990 24802127 34 1643734 1 1
2024-03-29 D xslFormDX01/primary_doc.xml 06b 0001601485-24-000017 021-509031 24801054 33 13979
2024-03-20 SC 13D/A SC 13D/A 0001193125-24-073005 005-93548 24769218 34 151281
2024-03-20 SC 13D/A GKCC, LLC SCHEDULE 13D/A 0001068238-24-000061 005-93548 24768271 34 78880
2024-03-20 4 4 0000950170-24-034198 7538
2024-03-18 8-K 8-K 1.01 0001601485-24-000015 001-39990 24756967 34 18052273 1 1
2024-02-05 4 FORM 4 0001140361-24-005499 5339
2024-02-05 4 FORM 4 0001140361-24-005498 5400
2024-02-05 4 FORM 4 0001140361-24-005497 5445
2024-02-05 4 FORM 4 0001140361-24-005496 7446
2024-02-02 8-K 8-K 5.02 0001601485-24-000013 001-39990 24588914 34 5161708 1 1
2024-01-17 8-K 8-K 8.01 0001601485-24-000009 001-39990 24536808 34 1689309 1 1
2024-01-16 8-K 8-K 8.01 0001601485-24-000006 001-39990 24533682 34 153810 1 1
2024-01-09 8-K 8-K 8.01,9.01 0001140361-24-001416 001-39990 24521761 34 4552640 1 1
2024-01-05 D xslFormDX01/primary_doc.xml 06b 0001140361-24-001004 021-501744 24516234 33 12980
2023-12-29 4 FORM 4 0001140361-23-060239 5395
2023-12-29 4 xslF345X05/form4.xml 0001140361-23-060238 5507
2023-12-29 4 FORM 4 0001140361-23-060237 5455
2023-12-29 4 xslF345X05/form4.xml 0001140361-23-060234 5406
2023-12-29 4 FORM 4 0001140361-23-060235 5453
2023-12-29 4 FORM 4 0001140361-23-060236 5450
2023-12-29 4 FORM 4 0001140361-23-060233 5303
2023-12-27 SC 13D/A SC 13D/A 0001193125-23-303990 005-93548 231518010 34 128432
2023-12-26 4 FORM 4 SUBMISSION 0001209191-23-059683 6639
2023-12-26 SC 13D/A GKCC SCHEDULE 13D/A 0001068238-23-000251 005-93548 231513603 34 76903
2023-12-22 8-K 8-K 1.01,3.02,8.01,9.01 0001601485-23-000086 001-39990 231507414 34 12265038 1 1
2023-11-13 10-Q 10-Q 0001601485-23-000082 001-39990 231395498 34 9297812 1 1
2023-11-09 8-K 8-K 2.02 0001601485-23-000077 001-39990 231393301 34 2022213 1 1
2023-11-03 8-K 8-K 8.01 0001601485-23-000071 001-39990 231377301 34 211904 1 1
2023-10-20 8-K 8-K 5.02 0001601485-23-000065 001-39990 231335981 34 2996408 1 1
2023-10-12 8-K 8-K 5.02 0001601485-23-000062 001-39990 231321728 34 153358 1 1
2023-09-28 8-K 8-K 8.01 0001601485-23-000060 001-39990 231285591 34 3974344 1 1
2023-09-07 8-K 8-K 8.01 0001601485-23-000057 001-39990 231241004 34 202297 1 1
2023-08-30 SC 13D/A SC 13D/A 0001193125-23-225024 005-93548 231226107 34 128151
2023-08-30 8-K 8-K 5.02 0001601485-23-000055 001-39990 231225677 34 150942 1 1
2023-08-21 S-8 S-8 0001140361-23-040740 333-274127 231190212 33 248517
2023-08-14 8-K/A 8-K/A 9.01 0001140361-23-039343 001-39990 231165887 34 2895928 1 1
2023-08-14 10-Q 10-Q 0001601485-23-000052 001-39990 231165867 34 5952821 1 1
2023-08-11 8-K 8-K 2.02,9.01 0001601485-23-000048 001-39990 231162334 34 233448 1 1
2023-07-07 SC 13G/A SC 13G/A 0001193125-23-183388 005-93548 231075373 34 90126
2023-06-14 SC 13D/A SC 13D/A 0001601485-23-000043 005-93548 231014104 34 66860
2023-06-14 SC 13D GKCC LLC SCHEDULE 13D 0001068238-23-000119 005-93548 231013867 34 67420
2023-06-12 3 xslF345X02/form3.xml 0001140361-23-029321 14756
2023-06-12 3 xslF345X02/form3.xml 0001140361-23-029320 15714
2023-06-12 SC 13D SC 13D 0001193125-23-165265 005-93548 231007986 34 167756
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028873 27418
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028872 14755
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028868 17846
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028867 17495
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028863 21254
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028860 17802
2023-06-07 3 xslF345X02/form3.xml 0001140361-23-028858 16684
2023-06-05 4 xslF345X04/form4.xml 0001140361-23-028420 5518
2023-06-05 3 xslF345X02/form3.xml 0001140361-23-028408 11292
2023-06-05 8-K 8-K 8.01,9.01 0001140361-23-028235 001-39990 23991254 34 214374 1 1
2023-06-02 8-K 8-K 2.01,3.03,4.01,5.01,5.02,5.03,5.07,7.01,8.01,9.01 0001140361-23-028077 001-39990 23989492 34 8421324 1 1
2023-05-30 425 425 0001140361-23-027264 001-39990 23977193 34 25317
2023-05-30 8-K 8-K 8.01 0001140361-23-027259 001-39990 23977111 34 173220 1 1
2023-05-24 425 425 0001140361-23-026314 001-39990 23950374 34 221452
2023-05-24 8-K 8-K 8.01 0001140361-23-026313 001-39990 23950367 34 435292 1 1
2023-05-10 10-Q 10-Q 0001601485-23-000035 001-39990 23906521 34 5506308 1 1
2023-05-01 8-K 8-K 8.01,9.01 0001601485-23-000032 001-39990 23873822 34 1019361 1 1
2023-04-28 SEC STAFF LETTER filename1.pdf 9999999997-23-002482 278973
2023-04-28 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-04-28 16:00:00 9999999995-23-001104 333-269741 23869664 33 1657
2023-04-28 10-K/A 10-K/A 0001601485-23-000028 001-39990 23867146 34 407610 1 1
2023-04-28 424B3 424B3 0001140361-23-021521 333-269741 23866023 33 15044846
2023-04-27 8-K 8-K 8.01,9.01 0001601485-23-000021 001-39990 23858549 34 1107807 1 1
2023-04-27 S-4/A FORM S-4/A 0001140361-23-020658 333-269741 23851434 33 31818756 1 1
2023-04-26 CORRESP filename1.htm 0001140361-23-020659 19659
2023-04-21 CORRESP filename1.htm 0001140361-23-019610 21056
2023-04-21 S-4/A FORM S-4/A 0001140361-23-019606 333-269741 23836652 33 31856321 1 1
2023-04-20 UPLOAD filename1.pdf 0000000000-23-003960 44429
2023-04-13 CORRESP filename1.htm 0001140361-23-018256 73297
2023-04-13 S-4/A FORM S-4/A 0001140361-23-018253 333-269741 23818981 33 29646569 1 1
2023-04-07 UPLOAD filename1.pdf 0000000000-23-003514 50032
2023-04-06 SEC STAFF LETTER filename1.pdf 9999999997-23-001618 280035
2023-03-29 CORRESP filename1.htm 0001140361-23-014581 182928
2023-03-29 S-4/A FORM S-4/A 0001140361-23-014578 333-269741 23776304 33 31514269 1 1
2023-03-17 S-8 FORM S-8 0001140361-23-012355 333-270676 23743773 33 91687
2023-03-17 10-K 10-K 0001601485-23-000011 001-39990 23742957 34 15836607 1 1
2023-03-14 8-K 8-K 1.01,1.02 0001601485-23-000004 001-39990 23730669 34 172149 1 1
2023-03-10 UPLOAD filename1.pdf 0000000000-23-002386 79159
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-039214 005-93548 23629856 34 45801
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021175 005-93548 23625344 34 41452
2023-02-13 S-4 FORM S-4 0001140361-23-006407 333-269741 23620137 33 38982627 1 1
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032786 005-93548 23612963 34 43185
2023-01-18 425 425 0001140361-23-001999 001-39990 23534933 34 65049
2023-01-18 425 425 0001140361-23-001996 001-39990 23534918 34 6785355
2023-01-18 425 425 0001140361-23-001994 001-39990 23534907 34 30454
2023-01-17 425 425 0001140361-23-001716 001-39990 23530098 34 29725
2023-01-17 425 425 0001140361-23-001715 001-39990 23530095 34 1163305
2023-01-17 8-K FORM 8-K 1.01,5.02,8.01,9.01 0001140361-23-001714 001-39990 23530091 34 1533827 1 1
2022-12-22 8-K 8-K 3.01 0001601485-22-000073 001-39990 221479479 34 175957 1 1
2022-11-14 10-Q 10-Q 0001601485-22-000070 001-39990 221385935 34 12550773 1 1
2022-08-15 10-Q 10-Q 0001601485-22-000066 001-39990 221166489 34 6902169 1 1
2022-08-15 8-K 8-K 2.02,9.01 0001601485-22-000064 001-39990 221165899 34 100499
2022-07-25 8-K 8-K 2.05,5.02 0001601485-22-000061 001-39990 221103890 34 22005
2022-07-11 4 FORM 4 0001601485-22-000059 4780
2022-06-29 8-K 8-K 2.02 0001601485-22-000057 001-39990 221054779 34 18079
2022-06-14 8-K 8-K 5.07 0001601485-22-000055 001-39990 221013047 34 178286 1 1
2022-06-13 4 FORM 4 0001601485-22-000053 5223
2022-06-13 4 FORM 4 0001601485-22-000052 5320
2022-06-13 4 FORM 4 0001601485-22-000051 5381
2022-06-13 4 FORM 4 0001601485-22-000050 5361
2022-05-27 4/A FORM 4/A 0001601485-22-000045 9844
2022-05-27 4/A FORM 4/A 0001601485-22-000044 8253
2022-05-27 4 FORM 4 0001601485-22-000043 4492
2022-05-25 4 FORM 4 0001601485-22-000039 5905
2022-05-24 424B5 424B5 0001104659-22-064218 333-264994 22956606 33 184347
2022-05-24 424B3 424B3 0001104659-22-064215 333-264994 22956590 33 336572
2022-05-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-23 16:00:00 9999999995-22-001571 333-264994 22953718 33 1689
2022-05-23 4 FORM 4 0001628280-22-015238 6307
2022-05-19 UPLOAD filename1.pdf 0000000000-22-005561 40199
2022-05-19 CORRESP filename1.htm 0001104659-22-062970 7913
2022-05-19 SC 13G SC 13G 0001193125-22-154648 005-93548 22941430 34 42410
2022-05-16 S-8 FORM S-8 0001104659-22-061513 333-264995 22931123 33 119758
2022-05-16 S-3 S-3 0001104659-22-061510 333-264994 22931086 33 1563534
2022-05-16 10-Q 10-Q 0001601485-22-000037 001-39990 22929194 34 6705497 1 1
2022-05-16 8-K 8-K 2.02,9.01 0001601485-22-000036 001-39990 22928783 34 255511 1 1
2022-04-27 SC 13G SC 13G 0001601485-22-000032 005-93548 22859653 34 96338
2022-04-27 SC 13D SC 13D 0001601485-22-000030 005-93548 22859592 34 57318
2022-04-27 DEFA14A DEF 14A 0001601485-22-000028 001-39990 22859524 34 1155561
2022-04-27 DEF 14A DEF 14A 0001601485-22-000026 001-39990 22859480 34 1273876
2022-03-30 10-K 10-K 0001601485-22-000022 001-39990 22787301 34 16101261 1 1
2022-03-30 8-K 8-K 2.02,9.01 0001601485-22-000020 001-39990 22787245 34 264941 1 1
2022-03-30 SC 13G SC 13G 0001193125-22-089720 005-93548 22786283 34 88562
2022-03-04 4 FORM 4 0001601485-22-000014 7742
2022-03-04 4 FORM 4 0001601485-22-000013 7711
2022-03-04 4 FORM 4 0001601485-22-000012 7767
2022-03-04 4 FORM 4 0001601485-22-000011 5463
2022-03-04 8-K 8-K 5.02 0001601485-22-000010 001-39990 22714285 34 189325 1 1
2022-02-14 SC 13G SC 13G 0001104659-22-023261 005-93548 22635223 34 42381
2022-01-04 8-K 8-K 2.02,2.05 0001601485-22-000004 001-39990 22506906 34 174180 1 1
2021-12-29 4 FORM 4 0001601485-21-000095 6388
2021-12-22 4 FORM 4 0001601485-21-000093 4783
2021-12-21 4 FORM 4 0001601485-21-000091 4849
2021-12-20 4 FORM 4 0001601485-21-000089 6387
2021-12-17 4 FORM 4 0001601485-21-000087 6150
2021-12-16 4 FORM 4 0001601485-21-000085 4480
2021-12-15 4 FORM 4 0001601485-21-000083 5126
2021-12-07 4 FORM 4 0001601485-21-000081 4942
2021-12-03 4 FORM 4 0001601485-21-000079 8223
2021-11-22 4 FORM 4 0001601485-21-000077 4847
2021-11-17 4 FORM 4 0001601485-21-000075 8186
2021-11-16 4 FORM 4 0001601485-21-000072 4888
2021-11-12 8-K 8-K 2.02,9.01 0001601485-21-000070 001-39990 211399494 34 278452 1 1
2021-11-12 10-Q 10-Q 0001601485-21-000068 001-39990 211399489 34 8599796 1 1
2021-10-26 8-K 8-K 2.02 0001601485-21-000064 001-39990 211348550 34 171536 1 1
2021-10-20 4 FORM 4 0001601485-21-000062 4829
2021-10-15 4 FORM 4 0001601485-21-000060 4888
2021-09-21 4 FORM 4 0001601485-21-000058 5068
2021-09-15 4 FORM 4 0001601485-21-000056 4889
2021-08-31 4 FORM 4 SUBMISSION 0001209191-21-054163 5043
2021-08-30 8-K 8-K 1.02 0001601485-21-000054 001-39990 211220899 34 173722 1 1
2021-08-23 3 FORM 3 SUBMISSION 0001209191-21-052939 3845
2021-08-19 4 FORM 4 0001601485-21-000052 4829
2021-08-17 4 FORM 4 0001601485-21-000050 4889
2021-08-12 8-K 8-K 2.02,9.01 0001601485-21-000048 001-39990 211167624 34 279737 1 1
2021-08-12 10-Q 10-Q 0001601485-21-000047 001-39990 211167609 34 8497726 1 1
2021-07-22 4 FORM 4 0001601485-21-000040 4889
2021-07-22 4 FORM 4 0001601485-21-000038 4830
2021-07-20 4/A FORM 4/A 0001601485-21-000036 4138
2021-07-15 4 FORM 4 0001601485-21-000033 4889
2021-06-29 8-K 8-K 8.01 0001601485-21-000031 001-39990 211058199 34 174749 1 1
2021-06-21 4 FORM 4 0001601485-21-000029 4830
2021-06-16 4 FORM 4 0001601485-21-000027 4889
2021-05-19 4 FORM 4 0001601485-21-000025 4829
2021-05-18 4 FORM 4 0001601485-21-000023 4888
2021-05-17 8-K 8-K 2.02,9.01 0001601485-21-000019 001-39990 21927345 34 98216
2021-05-17 10-Q 10-Q 0001601485-21-000017 001-39990 21927266 34 8439707 1 1
2021-04-20 4 FORM 4 0001601485-21-000013 4805
2021-04-15 4 FORM 4 0001601485-21-000011 4905
2021-03-30 8-K 8-K 2.02,9.01 0001601485-21-000009 001-39990 21787433 34 119158
2021-03-30 10-K 10-K 0001601485-21-000007 001-39990 21787355 34 4004908
2021-03-19 4 FORM 4 0001567619-21-006685 4801
2021-03-16 4 FORM 4 0001567619-21-006400 4860
2021-03-10 8-K FORM 8-K 5.02 0001104659-21-034451 001-39990 21729866 34 206017 1 1
2021-03-10 4 FORM 4 0001567619-21-005972 5248
2021-03-10 4 FORM 4 0001567619-21-005971 5406
2021-03-10 4 FORM 4 0001567619-21-005970 5344
2021-03-10 4 FORM 4 0001567619-21-005969 5386
2021-02-19 3/A FORM 3/A 0001567619-21-004527 7337
2021-02-17 4 FORM 4 0001567619-21-004331 4846
2021-02-11 4 FORM 4 0001567619-21-003193 18384
2021-02-11 4 FORM 4 0001567619-21-003192 7016
2021-02-11 4 FORM 4 0001567619-21-003191 15581
2021-02-11 4 FORM 4 0001567619-21-003190 4984
2021-02-11 4 FORM 4 0001567619-21-003189 16945
2021-02-09 S-8 FORM S-8 0001104659-21-016732 333-252906 21607337 33 140622
2021-02-09 8-K FORM 8-K 1.01,3.02,5.03,8.01,9.01 0001104659-21-016652 001-39990 21606307 34 717111 1 1
2021-02-08 4 FORM 4 0001567619-21-002413 5525
2021-02-08 4 FORM 4 0001567619-21-002412 5535
2021-02-08 4 FORM 4 0001567619-21-002411 5519
2021-02-08 4 FORM 4 0001567619-21-002410 5582
2021-02-05 424B4 424B4 0001047469-21-000304 333-252177 21597157 33 4754388
2021-02-04 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-02-04 16:00:00 9999999995-21-000447 333-252177 21593287 33 1689
2021-02-04 3 FORM 3 0001567619-21-002218 13644
2021-02-04 3 FORM 3 0001567619-21-002217 20026
2021-02-04 3 FORM 3 0001567619-21-002216 14673
2021-02-04 3 FORM 3 0001567619-21-002215 14652
2021-02-04 3 FORM 3 0001567619-21-002214 12198
2021-02-04 3 FORM 3 0001567619-21-002213 17600
2021-02-04 3 FORM 3 0001567619-21-002212 19657
2021-02-04 3 FORM 3 0001567619-21-002211 13600
2021-02-04 3 FORM 3 0001567619-21-002209 14703
2021-02-04 CERT 8A_Cert_ANGN.pdf 0001354457-21-000164 001-39990 21590232 34 257822
2021-02-04 8-A12B/A 8-A12B/A 0001104659-21-012085 001-39990 21590188 34 21268
2021-02-04 S-1/A S-1/A 0001047469-21-000278 333-252177 21588770 33 4913337
2021-02-02 CORRESP filename1.htm 0001104659-21-010892 16835
2021-02-02 CORRESP filename1.htm 0001104659-21-010891 11778
2021-02-02 8-A12B 8-A12B 0001104659-21-010887 001-39990 21581308 34 21689
2021-02-01 SEC STAFF LETTER filename1.pdf 9999999997-21-000475 275517
2021-02-01 S-1/A S-1/A 0001047469-21-000234 333-252177 21574511 33 6151669
2021-01-26 CORRESP filename1.htm 0001104659-21-007842 262662
2021-01-15 CORRESP filename1.htm 0001104659-21-004845 37521
2021-01-15 S-1 S-1 0001047469-21-000107 333-252177 21533045 33 8548589
2020-12-18 UPLOAD filename1.pdf 0000000000-20-012204 45379
2020-12-15 DRSLTR filename1.htm 0001104659-20-135791 34542
2020-12-15 DRS/A filename1.htm 0001104659-20-135785 377-03054 201390252 33 6655973
2020-06-23 D xslFormDX01/primary_doc.xml 06b 0001601485-20-000004 021-369538 20982096 33 12310
2020-05-27 UPLOAD filename1.pdf 0000000000-20-004698 43882
2020-05-13 DRSLTR filename1.htm 0000912057-20-000158 75508
2020-05-13 DRS/A filename1.htm 0000912057-20-000157 377-03054 20874219 33 3745373
2020-03-10 UPLOAD filename1.pdf 0000000000-20-002147 64948
2020-03-10 SEC STAFF LETTER filename1.pdf 9999999997-20-001208 279153
2020-02-14 DRS filename1.htm 0000912057-20-000078 377-03054 20620061 33 3084222
2020-01-27 D xslFormDX01/primary_doc.xml 06b 0001601485-20-000002 021-358981 20548121 33 10540
2020-01-13 D xslFormDX01/primary_doc.xml 06b 0001601485-20-000001 021-357840 20523658 33 10613
2018-07-17 D xslFormDX01/primary_doc.xml 06b 0001601485-18-000002 021-317100 18956647 33 16456
2018-07-17 D xslFormDX01/primary_doc.xml 06b 0001601485-18-000001 021-317099 18956636 33 8906
2015-02-20 D xslFormDX01/primary_doc.xml 06b 0001571049-15-001301 021-234480 15636489 33 7950
2014-10-24 RW RW 0001571049-14-005404 333-195261 141172981 NE 39485
2014-08-25 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001571049-14-004196 333-195261 141061322 33 6786081
2014-05-23 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001571049-14-002067 333-195261 14867843 33 6678230
2014-04-14 S-1 FORM S-1 0001571049-14-001179 333-195261 14763279 33 7236169
2014-03-04 DRS filename1.htm 0001571049-14-000679 377-00507 14665429 33 5213468

Latest XBRL company facts

One latest value per concept from companyfacts (306 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 28.31M 2026-11-03 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
dei EntityPublicFloat Entity Public Float USD 81.80M 2025-06-30 2025 FY 10-K/A 2026-04-29 0001601485-26-000035
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 379,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 628,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -127,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 280.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 150,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 300,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0001601485-25-000074
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.11M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 200,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 10,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 641,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 228,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 300,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap Assets Assets USD 39.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AssetsCurrent Assets, Current USD 34.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 6.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap CashAcquiredInExcessOfPaymentsToAcquireBusiness Cash Acquired in Excess of Payments to Acquire Business USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 30.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 6.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 31.41M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 12.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.68 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.26M 2025-01-31 2025 Q3 10-Q 2025-11-13 0001601485-25-000124
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.19M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 28.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 28.31M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CommonStockValue Common Stock, Value, Issued USD 283,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -28.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 20.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 0 2025-03-31 2025 Q1 10-Q 2025-05-13 0001601485-25-000074
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2021-02-10 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap CostOfRevenue Cost of Revenue USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap CostsAndExpenses Costs and Expenses USD 29.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.41M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-12 0001601485-21-000068
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 11.57 2021-02-09 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001601485-22-000037
us-gaap DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent USD 0 2023-12-31 2023 FY 10-K 2024-03-29 0001601485-24-000023
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -11.24M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 1.19M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 47.16M 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 77.26M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.02M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 5.02M 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 16.53M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 13.41M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.00M 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 149,000 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 110.30M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.22M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 8,000 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 53,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap Depreciation Depreciation USD 113,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.32 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.32 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.002 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.214 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.003 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.014 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.029 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap EffectiveIncomeTaxRateReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 8.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap EquityMethodInvestmentDividendsOrDistributions Proceeds from Equity Method Investment, Distribution USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -2.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 13.98M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 0 2022-01-01 2022-12-31 2023 Q3 10-Q 2023-11-13 0001601485-23-000082
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 114,000 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 36,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 265,000 2022-06-30 2022 Q2 10-Q 2022-08-15 0001601485-22-000066
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 219,000 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 94,000 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 31,000 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 31,000 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 94,000 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 25,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0001601485-22-000070
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1,000 2022-06-30 2022 Q2 10-Q 2022-08-15 0001601485-22-000066
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 15,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.011 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD -52,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -39.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -27.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -95,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 55,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 10.04M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 20,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -8.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 244,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 310,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -293,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -749,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 55,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap InterestExpense Interest Expense USD 36,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001601485-24-000033
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 469,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 150,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001601485-24-000033
us-gaap InterestIncomeOperatingAndNonoperating InterestIncomeOperatingAndNonoperating USD 776,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 532,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap Investments Investments USD 150,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 9.14M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LeaseCost Lease, Cost USD 27,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 253,000 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 253,000 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 253,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.51M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 347,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 648,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap Liabilities Liabilities USD 20.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 39.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LiabilitiesCurrent Liabilities, Current USD 9.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 408,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LongTermDebt Long-term Debt USD 10.00M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 2.48M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 4.21M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 5.79M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 7.16M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 42.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -16,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -30.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -28.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap NotesIssued1 Notes Issued USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001601485-24-000075
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -29.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseCost Operating Lease, Cost USD 27,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 3.00M 2022-01-01 2022-12-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.25M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.04M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 743,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 292.30M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap OtherAssetsCurrent Other Assets, Current USD 405,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 864,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 81,000 2022-06-30 2022 Q2 10-Q 2022-08-15 0001601485-22-000066
us-gaap OtherShortTermBorrowings Other Short-term Borrowings USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.40M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001601485-22-000070
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 228,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 500,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001601485-26-000056
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 10.00M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 16,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 825,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PrepaidInsurance Prepaid Insurance USD 435,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PrepaidTaxes Prepaid Taxes USD 305,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 13.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001601485-24-000023
us-gaap ProceedsFromIssuanceOfSeniorLongTermDebt Proceeds from Issuance of Senior Long-term Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001601485-22-000070
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ProceedsFromSecuredLinesOfCredit Proceeds from Secured Lines of Credit USD 700,000 2023-06-01 2023-06-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 117,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.05M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 182,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 9.68M 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 18.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 515,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 515,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 200,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap RestructuringCharges Restructuring Charges USD 9.20M 2022-01-01 2022-12-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 242,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap RestructuringSettlementAndImpairmentProvisions Restructuring, Settlement and Impairment Provisions USD 9.19M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -261.69M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap RevenueNotFromContractWithCustomer Revenue Not from Contract with Customer USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap Revenues Revenues USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-29 0001601485-24-000023
us-gaap SaleLeasebackTransactionNetBookValue Sale Leaseback Transaction, Net Book Value USD 200,000 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 5.38M 2023-06-01 2024 Q3 10-Q 2024-11-13 0001601485-24-000075
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 16 2021-02-09 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap SeveranceCosts1 Severance Costs USD 6.20M 2022-01-01 2022-12-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.797 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-13 0001601485-25-000074
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.795 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001601485-26-000056
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 478,708 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 15.94 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 212,909 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001601485-22-000037
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 2,347 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.36 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10.76 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 9.26 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001601485-22-000037
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap ShortTermNonBankLoansAndNotesPayable Short-term Non-bank Loans and Notes Payable USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 3.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 18.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.556 2021-02-01 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 23,490 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 7.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0001601485-25-000049
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.20M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 2.71M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 17,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 1.22M 2021-04-01 2021-06-30 2022 Q3 10-Q 2022-11-14 0001601485-22-000070
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 500,000 2022-03-01 2022 Q3 10-Q 2022-11-14 0001601485-22-000070
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-09-30 2024 Q3 10-Q 2024-11-13 0001601485-24-000075
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.06 2022-12-31 2023 FY 10-K 2024-03-29 0001601485-24-000023
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 6.95M 2022-12-31 2023 FY 10-K 2024-03-29 0001601485-24-000023
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 5.00M 2022-12-31 2023 FY 10-K 2024-03-29 0001601485-24-000023
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-09-30 2024 Q3 10-Q 2024-11-13 0001601485-24-000075
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 111.06M 2023-04-01 2023-06-30 2024 Q3 10-Q 2024-11-13 0001601485-24-000075
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 14,455 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap TreasuryStockValue Treasury Stock, Value USD 0 2021-12-31 2021 FY 10-K 2022-03-30 0001601485-22-000022
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 4.14M 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 386,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 246,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2022-12-31 2022 FY 10-K 2023-03-17 0001601485-23-000011
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 10.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001601485-26-000027
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-10 0001601485-23-000035
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 21.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 21.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001601485-26-000066

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →